"CHI Health Clinic Cardiology (CUMC - Bergan Mercy) is dedicated to delivering high quality, compassionate care to Omaha and nearby communities. Visit us at 7500 Mercy Rd or call (402) 398-5880 for more information."

During the past decade, Bergan Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bergan Cardiology" are "Atrial Fibrillation" (1 trials), "Bleeding" (1 trials), "In-Stent Restenosis" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Bergan Cardiology" in a lesser frequency.

Most popular intervention types in "Bergan Cardiology" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGENT DCB" (1 trials), "Non-Vitamin K Oral Anticoagulant" (1 trials), "PTCA balloon catheter" (1 trials) and "WATCHMAN FLX LAAC Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bergan Cardiology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bergan Cardiology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bergan Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bergan Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".